Dipl.-Ing. Dr. Melanie Grandits


van der Noord, VE, van der Stel, W, Louwerens, G, Verhoeven, D, Kuiken, HJ, Lieftink, C, Grandits, M, Ecker, GF, Beijersbergen, RL, Bouwman, P, Le Dévédec, SE & van de Water, B 2023, 'Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors', Breast Cancer Research, vol. 25, no. 1, 51, pp. 51. https://doi.org/10.1186/s13058-023-01648-x


Brecklinghaus, T, Albrecht, W, Kappenberg, F, Duda, J, Vartak, N, Edlund, K, Marchan, R, Ghallab, A, Cadenas, C, Günther, G, Leist, M, Zhang, M, Gardner, I, Reinders, J, Russel, FGM, Foster, AJ, Williams, DP, Damle-Vartak, A, Grandits, M, Ecker, G, Kittana, N, Rahnenführer, J & Hengstler, JG 2022, 'The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds', Chemico-Biological Interactions, vol. 351, 109728. https://doi.org/10.1016/j.cbi.2021.109728

Superti-Furga, G, Lackner, D, Wiedmer, T, Ingles-Prieto, A, RESOLUTE consortium & Steppan, C 2020, 'The RESOLUTE consortium: unlocking SLC transporters for drug discovery', Nature Reviews. Drug Discovery, vol. 19, no. 7, pp. 429-430. https://doi.org/10.1038/d41573-020-00056-6




Schuetz, DA, Richter, L, Amaral, M, Grandits, M, Graedler, U, Musil, D, Buchstaller, H-P, Eggenweiler, H-M, Frech, M & Ecker, GF 2018, 'Ligand Desolvation steers on-rate and impacts Drug Residence Time of Heat shock protein 90 (Hsp90) Inhibitors', Journal of Medicinal Chemistry, vol. 61, no. 10, pp. 4397–4411. https://doi.org/10.1021/acs.jmedchem.8b00080


Department of Pharmaceutical Sciences

EDV-Beauftragte

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E403

melanie.grandits@univie.ac.at